The chemokine interleukin‐8 and the surface activation protein CD69 are markers for Bcr–Abl activity in chronic myeloid leukemia

We have identified differentially regulated genes in chronic myeloid leukemia (CML) cells upon short treatment with the broad‐spectrum Bcr–Abl inhibitor dasatinib. The highly specific Bcr–Abl inhibitor nilotinib caused a very similar gene expression signature, validating the identified differentiall...

Full description

Saved in:
Bibliographic Details
Published in:Mol Oncol
Main Authors: Hantschel, Oliver, Gstoettenbauer, Agnes, Colinge, Jacques, Kaupe, Ines, Bilban, Martin, Burkard, Thomas R., Valent, Peter, Superti-Furga, Giulio
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2008
Subjects:
Papers
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5527809/
https://ncbi.nlm.nih.gov/pubmed/19383348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2008.07.003
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items